Preprint (JMIR Preprints) http://preprints.jmir.org/preprint/56993
Authors' Response to Peer-Review Reports https://med.jmirx.org/2024/1/e60174
Published Article https://med.jmirx.org/2024/1/e56993
doi:10.2196/60389
Keywords
This is the peer-review report for “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals.”
Round 1 Review
General Comments
This paper [
] introduces a machine learning (ML) methodology for predicting hyperglycemia in one of the cohorts taken from a suburban Nigerian region. The authors present the details of the methodology for participant recruitment and screening, data analysis, and selection of ML models.Specific Comments
Major Comments
- The introduction and motivation behind the work are well written. However, there is not enough literature done on the ML aspect of noncommunicable disease prediction; please also cite some of the recent work where ML-based methods are used for noncommunicable disease prediction.
- Before selecting the features, was there any domain expert consulted? If yes, please provide reasoning on some aspect of feature selection.
- How were the different ML models selected for the experiment? Please elaborate on some selection criteria such as the combination of tree-based models with other ensemble approaches such as random forest.
Minor Comments
- In Table 2, please reduce the decimal precision up to 2 digits.
- Figure 1 could be improved with a flow diagram to provide better readability and details of each step.
Conflicts of Interest
None declared.
Reference
- Oyebola K, Ligali F, Owoloye A, et al. Machine learning–based hyperglycemia prediction: enhancing risk assessment in a cohort of undiagnosed individuals. JMIRx Med. 2024;5:e56993. [CrossRef]
Abbreviations
ML: machine learning |
Edited by Edward Meinert; This is a non–peer-reviewed article. submitted 09.05.24; accepted 09.05.24; published 11.09.24.
Copyright© Fakhare Alam. Originally published in JMIRx Med (https://med.jmirx.org), 11.9.2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIRx Med, is properly cited. The complete bibliographic information, a link to the original publication on https://med.jmirx.org/, as well as this copyright and license information must be included.